Delta-like ligand 3 (DLL3): an attractive actionable target in tumors with neuroendocrine origin

Introduction Neuroendocrine carcinomas are very aggressive tumors with few treatment options. DLL3 seems to be an optimal target for therapeutic intervention, as it is expressed mainly on the membrane of tumor cells with neuroendocrine origin.